<DOC>
	<DOCNO>NCT01969214</DOCNO>
	<brief_summary>Diosmectite IQP-MM-101 use diarrhoea control . Backed data several study demonstrate efficacy , investigator conduct study look efficacy safety IQP-MM-101 diarrhoea control .</brief_summary>
	<brief_title>Safety Efficacy IQP-MM-101 Reducing Symptoms Diarrhoea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Age 18 65 year Good general health Acute diarrhoea episode define least three watery stool per 24 hour period 48 hour less Acute diarrhoea presume infectious origin Patients usually normal bowel movement ( defecation ) onset diarrhoea , , least three normal stool per week three less normal stool per day Negative pregnancy test ( ß HCGtest ) woman child bear potential Written inform consent prerequisite subject enrollment Known sensitivity ingredient device Fever &gt; 38,5◦C Blood pu stool Dehydration require intravenous rehydration History chronic diarrhoea ( three loose watery stool per day least 12 week , consecutive , precede 12 month ) Use antidiarrhoeal agent month prior baseline Diarrhoea possibly induce antibiotic , laxative agent , thyroid hormone , colchicine Irritable bowel syndrome Any acute chronic disease could interfere evaluation study device Females pregnant lactating Subjects participate another clinical trial 30 day treatment period Inability comply Presence factor ( ) , investigator 's judgement , preclude subject participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>